Biological therapy for severe asthma – Indian perspectives and challengesReview Published on 2023-04-282024-09-04 Journal: Lung India [Category] 대상포진, [키워드] Biological monoclonal antibodies Patient perspectives Severe asthma [DOI] 10.4103/lungindia.lungindia_432_22 PMC 바로가기 [Article Type] Review
SARS-Cov-2 Infection in Severe Asthma Patients Treated With BiologicsArticle Published on 2022-10-012022-11-15 Journal: The journal of allergy and clinical immunology. In [Category] COVID19(2023년), SARS, 진단, [키워드] acute respiratory syndrome administration Admission adverse outcome asked Asthma benralizumab biologic biologics characterized Cohort coronavirus coronavirus disease COVID-19 COVID-19 pandemic Deterioration died disease severity Exacerbation female General population Greece hospital infected patients Infection initial mechanical ventilation mepolizumab observé omalizumab outcome pandemic Patient patients treated physician polymerase chain provided required risk SARS-CoV-2 SARS-COV-2 infection Severe asthma severe COVID-19 severity systemic corticosteroids therapy treated Treatment was performed [DOI] 10.1016/j.jaip.2022.05.041 PMC 바로가기
Biologicals decrease psychological distress, anxiety and depression in severe asthma, despite Covid-19 pandemicArticle Published on 2022-08-012022-11-15 Journal: Respiratory medicine [Category] COVID19(2023년), SARS, 진단, [키워드] addition Affect Anxiety Asthma asthma patient Asthmatic patients benralizumab biologic Biological biological drug clinical disease Comorbidity decrease Depression depressive symptom disease drug evaluate female General population HADS Hypothesis independent males management Mental disorder mepolizumab monoclonal antibodies omalizumab pandemic parameters Patient patients treated Perceived stress Prevalence previous study problem PSS Psychiatric psychiatric disorder Psychological psychological disorders Psychological distress Quality of life reported Respiratory disease risk SARS-CoV-2 SARS-CoV-2 pandemic Severe asthma Stress treated Treatment [DOI] 10.1016/j.rmed.2022.106916 PMC 바로가기
Management of severe asthma during the first lockdown phase of SARS-CoV-2 pandemic: Tips for facing the second waveArticle Published on 2022-06-012023-07-06 Journal: Pulmonary pharmacology & therapeutics [Category] COVID19(2023년), [키워드] COVID-19 health-care management respiratory symptoms Severe asthma [DOI] 10.1016/j.pupt.2021.102083 PMC 바로가기
Asthma care during COVID-19: differences in attitudes and expectations between physicians and patientsArticle Published on 2022-05-012023-07-06 Journal: The Journal of asthma : official journal of the Association for the Care of [Category] COVID19(2023년), [키워드] Behavior pandemic Severe asthma specialist. survey [DOI] 10.1080/02770903.2021.1887214
Severe asthma and COVID-19: lessons from the first waveReview Published on 2022-02-012023-07-06 Journal: The Journal of asthma : official journal of the Association for the Care of [Category] COVID19(2023년), SARS, [키워드] Asthma biologic agents COVID-19 inhaled corticosteroids Oral corticosteroids SARS-CoV-2 Severe asthma [DOI] 10.1080/02770903.2020.1861622 [Article Type] Review
JAK inhibitors for asthmaArticle Published on 2022-01-072024-09-04 Journal: The Journal of Allergy and Clinical Immunology [Category] 대상포진, [키워드] Asthma JAK inhibitor JAK/STAT pathway Janus kinase Severe asthma [DOI] 10.1016/j.jaci.2021.08.013 PMC 바로가기 [Article Type] Article
COVID-19 in a Patient With Severe Eosinophilic Asthma on Benralizumab Therapy: A Case Report and Review of LiteratureAllergy/Immunology Published on 2021-12-232022-10-31 Journal: Cureus [Category] COVID-19, [키워드] acute respiratory syndrome addition Affect antiviral activity Asthma Asymptomatic COVID-19 benralizumab clinical status contribute coronavirus coronavirus disease Course COVID-19 COVID-19 patients COVID-19 prognosis cytotoxicity deplete Deterioration develop eosinophil Eosinophilic functions IL-5 immunoregulation Infection inflammatory reaction literature literature review modulation monoclonal antibody Patient positive report review SARS-CoV-2 Severe asthma severity of COVID-19 tested the disease therapy [DOI] 10.7759/cureus.20644 PMC 바로가기 [Article Type] Allergy/Immunology
Randomized, placebo controlled, double blinded pilot superiority phase 2 trial to evaluate the effect of curcumin in moderate to severe asthmatics중등도 내지 중증 천식에서 커큐민의 효과를 평가하기위한 무작위, 위약 제어, 이중 블라인드 파일럿 우월성 2 단계 시험Study Protocol Published on 2021-08-172022-09-01 Journal: BMC Pulmonary Medicine [Category] Fulltext, MERS, SARS, 비임상, 임상, 진단, [키워드] adjunct adopted anorexia Anti-inflammatory anti-inflammatory properties Anti-oxidant approved Arthritis Asthma baseline benefit blinded Blood breath by mouth can be used change clinic visit Clinic visits contribute control test COVID-19 COVID-19 pandemic Curcumin derivative determine Enzymes eosinophil Eosinophil count evaluate the effect finding Follow-up FVC IgE Inflammatory Inflammatory marker inflammatory markers institutional review board Intervention Lung diseases Lung inflammation matching placebo medical condition mice moderate Moderate asthma moderate to severe mouth pathway Patient patients with moderate Phase 2 phase 2 trial Placebo predicted Randomized receiving reducing reduction in screening visit Severe asthma shown Study design study period Study protocol therapeutic effect therapeutic effects therapy treat Treatment Trial registration university USA [DOI] 10.1186/s12890-021-01619-y PMC 바로가기 [Article Type] Study Protocol
COVID-19 Vaccination in Patients with Severe Asthma on Biologic Treatment: Safety, Tolerability, and Impact on Disease ControlArticle Published on 2021-08-042022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] absence administration adverse event allergy Asthma asthma patient asthmatic patient biologic biologics Control COVID 19 COVID-19 COVID-19 vaccination disease evaluate event hospital Impact life mRNA offered Patient Pfizer Pfizer mRNA SARS-CoV-2/COVID 19 vaccine positive attitude proportion Quality Quality of life questionnaire reported Safety second dose Severe asthma Side effect Side effects Support Test Tolerability Treatment undergo vaccination Vaccine [DOI] 10.3390/vaccines9080853 PMC 바로가기 [Article Type] Article